胆盐水解酶产生菌的筛选及其益生潜力研究

目的从健康仔猪肠道及粪便中筛选具有胆盐水解酶活性的优良益生乳杆菌菌株,并对筛选菌株的体外、体内益生潜力进行初步探讨。方法用MRS培养基分别从仔猪新鲜粪便和小肠黏膜分离培养乳酸菌,用筛选鉴别培养基筛选阳性菌株,研究菌株的抗逆能力、黏附特性以及体内益生活性。结果从粪便和小肠黏膜共得到乳酸菌388株和97株,其中胆盐水解酶阳性菌株分别为291株(75%)和86株(89%)。选择5株胆盐水解酶活性最强、能水解游离胆酸的菌株,研究菌株的抗逆能力、黏附特性以及体内益生活性,并对最终选育得到的菌株进行生理生化及16S rRNA分子鉴定,发现菌株罗伊乳杆菌G22-2能耐受pH 3.0的酸度、1.0%的胆盐浓度,在小肠上皮细胞上的黏附效率超过15个以上;通过大鼠体内实验,筛选出的菌株G22-2对大鼠无毒无害,并能显著改善血脂水平。结论罗伊乳杆菌G22-2符合益生菌的要求,可以作为产胆盐水解酶的益生乳杆菌优良的候选菌株。     

罗伊乳杆菌LE16益生特性的研究

目的研究罗伊乳杆菌LE16的益生特性。方法通过体外和动物实验,评价罗伊乳杆菌LE16的益生特性。结果该菌株对p H 2.5的强酸和0.3%高胆盐环境均有良好的耐受性。对引起肠道感染的几种病原菌均有不同程度的拮抗,尤其对枯草芽胞杆菌、伤寒沙门菌、单核细胞增生李斯特菌及蜡样芽胞杆菌的抑制作用最强。对肠道菌群正常和失调的小鼠均具有调节功能。结论罗伊乳杆菌LE16具有良好的益生性能,可作为益生菌菌株开发应用于食品和保健食品中。     

降解嘌呤核苷乳酸菌的筛选及益生特性探索

【背景】高尿酸血症是人体内嘌呤代谢紊乱导致的一种慢性代谢疾病,利用乳酸菌降解嘌呤类物质是辅助治疗高尿酸血症的新方法。【目的】筛选高效降解嘌呤核苷的乳酸菌并对其益生特性进行研究。【方法】利用HPLC法评价乳酸菌对肌苷、鸟苷的降解效果。通过药敏性试验、体外耐受性试验及细胞黏附试验研究目标菌株的益生特性。【结果】筛选出一株发酵乳杆菌(Lactobacillus fermentum) SR2-6,对肌苷和鸟苷的降解率分别为99.26%和98.85%。该菌株对青霉素、氯霉素等5种常见抗生素不具备耐药性,在pH 2.0环境下处理4 h后菌株的存活率为76.51%,在饱腹状态下的人工肠液模拟消化4 h后活菌数仍能达到6.85 lg (CFU/mL),对Caco-2细胞的黏附数为(52.29±15.14) CFU/cell。【结论】发酵乳杆菌SR2-6能够高效降解肌苷和鸟苷且具有优良的益生特性,是预防和治疗高尿酸血症的潜在优势菌株,可作为优势菌种资源应用于相关功能产品的开发。     

沼泽红假单胞菌2c菌株的安全性评价

本实验旨在对1株沼泽红假单胞菌Rhodopseudomonaspalustris2c菌株(2c)作为益生菌株的安全性进行系统研究。结果表明,2c菌株体外对多数抗生素敏感;在体内不具有急性毒性,不会在血液中产生内毒素,在宿主体内自身不会易位,也不会造成其它肠道细菌易位,对肝肾功能无不良影响,对回肠黏膜及其细胞形态和结构无不良影响。2c菌株具备益生菌安全特性,值得进一步研究。     

耐受微酸性次氯酸水乳酸菌的分离鉴定、耐受特性及益生特性

【背景】次氯酸水具有杀菌性，当其作为饮用水可能会对畜禽肠道内有益菌造成负面影响。【目的】筛选出具有耐受微酸性次氯酸水(slightly acidic hypochlorous acid water, SAHW)能力的乳酸菌并研究其益生特性。【方法】从内蒙古地区传统自然发酵制品中分离筛选出8株乳酸菌菌株，经16SrRNA基因测序进行鉴定。进一步通过耐受SAHW、耐酸、耐胆盐、疏水性及自凝聚能力试验进行耐受特性和益生特性研究。【结果】菌株MBH3-2为副干酪乳杆菌，其经过质量浓度为20mg/L的SAHW处理2h，菌落对数值仅下降0.3lg(CFU/mL)，存活率为50.10%；而且在酸性(pH 2.0、2.5和3.0)、胆盐环境下均可存活；疏水率达62.12%，属于高度疏水性；自凝聚能力在2 h达到97.29%。【结论】最终确定一株具有优良耐受SAHW及基本满足作为微生态制剂要求的菌株，MBH3-2具有作为新型微生态制剂菌株的潜力。     

模拟人体胃肠道环境筛选益生乳杆菌

【目的】筛选具有益生特性的乳杆菌作为保健型酸奶的候选菌株。【方法】从健康人肠道和奶豆腐中分离筛选出耐受人工胃液的乳杆菌,对其进行体外益生特性(人工胃肠液耐受性、胆盐耐受性、抑菌活性及胆固醇降解能力)研究。【结果】从在乳杆菌分离培养基上有溶钙圈的41株菌株中筛选出5株耐酸、耐人工胃液较强的菌株,经16S rR NA基因测序鉴定,其中3株为乳杆菌,分别命名为植物乳杆菌Lp MT-3、植物乳杆菌Lp MT-5和唾液乳杆菌LsA F-7。在人工胃液中3株菌的耐受力均强于商品化的对照菌株LGG(鼠李糖乳杆菌GG);转入肠液4 h后直至26 h,Lp MT-5存活率基本稳定在45%左右,仅次于LGG。胆盐浓度为0.10%时,3株乳杆菌的耐胆盐能力均强于LGG;胆盐浓度为0.20%时,Lp MT-3和LsA F-7仍能存活。3株乳杆菌均具有抑菌活性,对粪肠球菌的抑制最明显,其次是金黄色葡萄球菌,对大肠杆菌、沙门氏菌的抑制作用较差。3株乳杆菌对胆固醇的清除效力依次为Lp MT-3LpM T-5Ls AF-7;清除率依次为Ls AF-7Lp MT-3LpM T-5。【结论】筛选出3株适应人体胃肠液环境、耐胆盐、抑菌及降胆固醇活力强的乳杆菌,可作为进一步开发新的益生菌产品和保健型酸奶的菌株。     

具有改善去卵巢小鼠钙磷吸收作用的益生菌筛选与鉴定

通过评价六株乳酸菌耐酸耐胆盐能力、细胞黏附能力以及抗炎能力,筛选出一株同时具有耐酸耐胆盐、高黏附以及抗炎能力的乳酸菌AR281。结果表明,AR281在p H为2.5、3.5和4.5或胆盐浓度0.1%、0.2%和0.3%的条件下处理后,存活菌数均高于107CFU/m L;AR281对HT-29细胞的黏附数量高达350.60个/100细胞;同时AR281处理LPS诱导的巨噬细胞后,细胞NO的产量降低了20.64μmol/L。通过动物实验研究这株乳酸菌对机体钙磷吸收的调节作用发现,补充乳酸菌AR281后,摘卵巢后小鼠体内骨钙和骨磷的含量分别增加了8.51%和19.14%,同时尿钙的水平下降了47.54%。经16s r DNA菌株鉴定,确定AR281为短乳杆菌。     

弯曲广布乳杆菌 HFS9 基因组分析及益生特性

【背景】近年来,弯曲广布乳杆菌的健康益处受到广泛关注;基因组分析结合表型实验的方法为益生菌开发提供了新思路。【目的】探索分离自健康人粪便的弯曲广布乳杆菌HFS9基因组特征及益生潜力。【方法】通过泛基因组分析对弯曲广布乳杆菌基因组特征进行描述,基于功能数据库注释并分析HFS9益生相关基因;通过耐酸耐胆盐实验、自聚集、疏水性和细胞黏附实验、抗生素敏感性试验、自由基清除实验及抑菌试验等对HFS9的体外益生特性进行评估;构建小鼠结肠炎模型初步评估HFS9的体内抗炎作用。【结果】弯曲广布乳杆菌具有开放的泛基因组和保守的核心基因组。HFS9基因组大小为1.97 Mb,GC含量为41.86%,蛋白质编码区数目为2 050个;含乳杆菌噬菌体PLE3编码基因及与细胞黏附、酸耐受、胆盐耐受和抗氧化等相关的益生基因。HFS9在酸和胆盐环境中的存活率分别为62.42%和92.92%;自聚集能力和疏水性分别为63.33%和75.00%,对人结肠癌细胞(HT-29细胞)的黏附率为12.97%;对选用的大多数抗生素敏感;对6种常见人体致病菌均具有抑制作用;具有清除1,1-二苯基-2-三硝基苯肼[1,1-diphen...     

伯顿毕赤酵母菌在酸性及胆盐环境的抗逆性研究

目的探究伯顿毕赤酵母菌在酸性及胆盐环境下的益生特性,为研制益生菌制剂提供理论依据。方法采用稀释平板计数法,在pH 1.0、1.5、2.0、2.5、3.0和胆盐浓度0.1%、0.2%、0.3%、0.4%的PDA液体培养基以及人工胃液作用0、2、4h,人工肠液作用0、2、4、6、8、10h环境下,分别测定伯顿毕赤酵母菌的活菌数。结果耐酸实验中,各酸性实验组活菌数与对照组比较均下降明显(P0.01),酸度越高,活菌数越少;耐胆盐实验中,胆盐浓度越高,活菌含量越少,其中0.2%、0.3%和0.4%的胆盐浓度与对照组比较活菌数下降明显(P0.01);人工胃液实验中,经过pH 1.5人工胃液处理4h,菌株存活率达42.78%,而经过pH 2.5和3.5的人工胃液处理4h,存活率分别为138.17%和182.90%;人工肠液实验中,随着处理时间的延长,活菌数也增加,且不同时间段的活菌数差异有统计学意义(P0.05)。结论伯顿毕赤酵母菌能够在极高的酸性和较高的胆盐环境以及人工胃肠液环境中存活和定植,符合制备益生菌制剂的条件。     

全基因组测序揭示两株泡菜源植物乳杆菌基因型差异和潜在益生特性北大核心

【目的】为了探究植物乳杆菌(Lactiplantibacillus plantarum)基因型差异和潜在益生特性,采用全基因组测序技术对其进行测序并解析基因组序列及生物特性。【方法】本研究基于HiSeq和PacBio测序平台,对团队前期从四川多代泡菜中分离获得、体外益生特性评价良好的潜在益生菌菌株L.plantarum Eden-Star PC06和L.plantarum Eden-Star PC108的全基因组进行测序。利用相关生物信息学软件对原始数据进行组装及其后续的功能注释、分子进化、菌株安全性、次级代谢产物合成基因簇以及益生特性相关基因进行分析。【结果】通过基因组装得到了2株植物乳杆菌的全基因组信息,L.plantarum Eden-Star PC06和Eden-Star PC108基因组大小分别为3163902 bp和3205054 bp;GC含量分别为44.68%和44.67%;分别包含3161个和3197个DNA编码序列;功能基因数据库比对结果显示2株菌在碳水化合物利用、氨基酸利用和糖基转移酶等基因上得到大量注释;通过比对数据库,在2株植物乳杆菌全基因组上发现了4个与肠液耐受相关的胆盐水解酶基因、完整的植物乳杆菌细菌素合成相关基因簇和抵御多种胁迫的益生相关基因。【结论】本研究通过全基因组测序在基因水平上探究了L.plantarum Eden-Star PC06和Eden-Star PC108基因型差异和益生特性基因,证明L.plantarum Eden-Star PC06和Eden-Star PC108是2株有应用前景的益生菌菌株,以期为筛选优良益生菌菌株和评价其益生特性提供遗传学基础。     

Quantitative Appraisal of the Probiotic Attributes and In Vitro Adhesion Potential of Anti-listerial Bacteriocin-producing Lactic Acid Bacteria

Estimation of bile tolerance, endurance to gastric and intestinal environment and adhesion potential to intestinal cells are significant selection criteria for probiotic lactic acid bacteria (LAB). In this paper, the probiotic potential of native bacteriocin-producing LAB isolated previously from indigenous source has been determined through quantitative approaches. Among fifteen anti-listerial bacteriocin-producing native LAB, ten strains were found to be bile tolerant. The presence of bile salt hydrolase (bsh) gene in native Lactobacillus plantarum strains was detected by PCR and confirmed by nucleic acid sequencing of a representative amplicon. Interestingly, three native LAB strains exhibited significant viability in simulated gastric fluid, analogous to the standard LAB Lactobacillus rhamnosus GG, while an overwhelming majority of the native LAB strains demonstrated the ability to survive and remain viable in simulated intestinal fluid. Quantitative adhesion assays based on conventional plating method and a fluorescence-based method revealed that the LAB isolates obtained from dried fish displayed significant in vitro adhesion potential to human adenocarcinoma HT-29 cells, and the adhesion level was comparable to some of the standard probiotic LAB strains. The present study unravels putative probiotic attributes in certain bacteriocin-producing LAB strains of non-human origin, which on further in vivo characterization could find specific applications in probiotic food formulations targeted for health benefits.     

Polysorbate 80 improves the adhesion and survival of yogurt starters with cholesterol uptake abilities

The goal of this study is to improve the adhesion and survival of yogurt bacteria with probiotic traits by using polysorbate 80, a food additive emulsifier commonly found in milk derivative products. Polysorbate 80 was used at 1% (w/v), and its effects on yogurt bacteria's survival under simulated digestive conditions, cholesterol uptake activities, bile salt hydrolase (BSH) activity, and adhesion to HT-29 culture were studied. In the presence of 1% polysorbate 80, both starters demonstrated better cholesterol uptake and BSH activities, as well as higher bacterial survival at pH 2.5, particularly in associated cultures. In the presence of 0.3 % bile or cholic acid, polysorbate 80 reduced the drop in L. bulgaricus's survival load. However, the carbon source had a greater impact on S. thermophilus bile tolerance than the food additive emulsifier. Oleic acid was incorporated into both bacterial membranes when grown in the presence of bile and polysorbate 80, resulting in a higher unsaturated/saturated fatty acid ratio. In the presence of polysorbate 80, S. thermophilus adhered to HT-29 cells 2.3-fold better, while L. bulgaricus's adhesion remained unchanged. We suggest that polysorbate 80 may have a protective effect on cell survival under simulated digestive stress as well as a role in yogurt bacteria adhesion to the intestines, giving these bacteria more opportunities to exert their purported cholesterol-removal activities.     

Screening of bifidobacteria with acquired tolerance to human gastrointestinal tract

Tolerance capabilities of 38 Bifidobacterium strains were achieved by simulating the micro-environment of human gastrointestinal tract using modified MRSC broth (pH 3.0). Fourteen strains of them with high viability were obtained in MRSC with 0.3% bile salts. Sequently, six strains of bifidobacteria with higher survivability were picked in MRSC broth (pH 3.0) supplemented with 1-20mg/ml bile salt. Finally, strain A04 with the optimal ability was chosen for further studies. It had been seen that Bifidobacterium breve A04 had better survival capability to 0.5% pepsin (w/v) or 1% pancreatin (w/v) than other bifidobacteria, and viable bacteria were above 8.00 log cfu/ml after incubation for 24h. Meanwhile, it had higher adhesive capability to HT-29 cells in vitro and average adhesive bacteria numbers reached 12.8+/-0.9 for each HT-29 cell. The results indicated that the ability to tolerate gastroenteric environment and the adhesive capacity to HT-29 cells among Bifidobacterium strains was different. B. breve A04 has several aspects of advantages and may be regarded as potential probiotics.     

Genomic and physiological analyses of an indigenous strain, <Emphasis Type="Italic">Enterococcus faecium</Emphasis> 17OM39

The human gut microbiome plays a crucial role in human health and efforts need to be done for cultivation and characterisation of bacteria with potential health benefits. Here, we isolated a bacterium from a healthy Indian adult faeces and investigated its potential as probiotic. The cultured bacterial strain 17OM39 was identified as Enterococcus faecium by 16S rRNA gene sequencing. The strain 17OM39 exhibited tolerance to acidic pH, showed antimicrobial activity and displayed strong cell surface traits such as hydrophobicity and autoaggregation capacity. The strain was able to tolerate bile salts and showed bile salt hydrolytic (BSH) activity, exopolysaccharide production and adherence to human HT-29 cell line. Importantly, partial haemolytic activity was detected and the strain was susceptible to the human serum. Genomics investigation of strain 17OM39 revealed the presence of diverse genes encoding for proteolytic enzymes, stress response systems and the ability to produce essential amino acids, vitamins and antimicrobial compound Bacteriocin-A. No virulence factors and plasmids were found in this genome of the strain 17OM39. Collectively, these physiological and genomic features of 17OM39 confirm the potential of this strain as a candidate probiotic.     

长寿老人源双歧杆菌优良菌株的筛选

以人结肠腺癌细胞系HT-29细胞为试材,对来源于广西巴马百岁以上长寿老人肠道的24株双歧杆菌进行了体外黏附试验。结果发现,双歧杆菌均具有一定的黏附能力,其中TTF、Z2、TZ5和J-1菌株具有较高的黏附能力。进一步对4株初筛双歧杆菌耐胃酸、胆汁酸和合成B族维生素能力的试验发现,双歧杆菌TTF菌株不仅能合成较高的B1、B2、B6、B12等多种B族维生素,而且在pH3．0的条件下处理120min存活率达93．11％,同时在2％胆盐浓度下处理24h有较好的存活,具有显著的综合优势。     

Comparison of in vitro models to study bacterial adhesion to the intestinal epithelium

Aims:  To evaluate the adhesion ability of intestinal bacteria to different in vitro models of intestinal epithelia, and to estimate the suitability of these models and the type of interactions involved.
Methods and results:  The adhesion of probiotic ( Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp . lactis Bb12), commensal ( B. animalis IATA-A2 and B. bifidum IATA-ES2) and potentially pathogenic bacteria ( E. coli and L. monocytogenes ) was determined. The adhesion models used were polycarbonate-well plates, with or without mucin, and different configurations of Caco-2 and/or HT29-MTX cell cultures. All bacteria adhered to wells without mucin (2·6–27·3%), the values being highly variable depending on the bacterial strain. Adhesion percentages of potentially probiotic bacteria to Caco-2 cultures were remarkably lower ( P  <   0·05) than those to mucin, and more similar to those of pathogenic strains. The lowest adhesion of different bacterial strains was detected on HT29-MTX (0·5–2·3%) cultures and Caco-2/HT29-MTX (0·6–3·2%) cocultures, while these values were increased in Caco-2 cultures plus mucin.
Conclusions:  The results suggested that bacterial strains exhibit different capacities to adhere to cellular components and several types of mucin present in different models, showing preferences for intestinal MUC2.
Significance and impact of the study:  The use of Caco-2 cells monolayer plus mucin (type II) better approaches the physiological characteristics of in vivo situation, providing a reliable and suitable in vitro model to evaluate bacterial adhesion.     

Screening and Characterization of Purine Nucleoside Degrading Lactic Acid Bacteria Isolated from Chinese Sauerkraut and Evaluation of the Serum Uric Acid Lowering Effect in Hyperuricemic Rats

Hyperuricemia is well known as the cause of gout. In recent years, it has also been recognized as a risk factor for arteriosclerosis, cerebrovascular and cardiovascular diseases, and nephropathy in diabetic patients. Foods high in purine compounds are more potent in exacerbating hyperuricemia. Therefore, the development of probiotics that efficiently degrade purine compounds is a promising potential therapy for the prevention of hyperuricemia. In this study, fifty-five lactic acid bacteria isolated from Chinese sauerkraut were evaluated for the ability to degrade inosine and guanosine, the two key intermediates in purine metabolism. After a preliminary screening based on HPLC, three candidate strains with the highest nucleoside degrading rates were selected for further characterization. The tested biological characteristics of candidate strains included acid tolerance, bile tolerance, anti-pathogenic bacteria activity, cell adhesion ability, resistance to antibiotics and the ability to produce hydrogen peroxide. Among the selected strains, DM9218 showed the best probiotic potential compared with other strains despite its poor bile resistance. Analysis of 16S rRNA sequences showed that DM9218 has the highest similarity (99%) to Lactobacillus plantarum WCFS1. The acclimated strain DM9218-A showed better resistance to 0.3% bile salt, and its survival in gastrointestinal tract of rats was proven by PCR-DGGE. Furthermore, the effects of DM9218-A in a hyperuricemia rat model were evaluated. The level of serum uric acid in hyperuricemic rat can be efficiently reduced by the intragastric administration of DM9218-A (P<0.05). The preventive treatment of DM9218-A caused a greater reduction in serum uric acid concentration in hyperuricemic rats than the later treatment (P<0.05). Our results suggest that DM9218-A may be a promising candidate as an adjunctive treatment in patients with hyperuricemia during the onset period of disease. DM9218-A also has potential as a probiotic in the prevention of hyperuricemia in the normal population.     

Probiotic characteristics of Lactobacillus strains isolated from cheese and their antibacterial properties against gastrointestinal tract pathogens

In the present study, four Lactobacillus strains from the cheese were analyzed for its probiotic potential against enteropathogenic bacteria. The probiotic properties of the selected strains were also analyzed and the selected bacterial strains showed high tolerance in bile salts and organic acid. The strain L. plantarum LP049 showed maximum survival rate (92 ± 4.2% and 93.3 ± 2%) after 3 h of treatment at 0.25% (w/v) bile salts and 0.25% (w/v) organic acid concentrations. The ability of the Lactobacillus strains to adhere to human epithelial cells (HT-29 cell lines) was evaluated and L. plantarum LP049 showed maximum adhesion property (19.2 ± 1.1%) than other tested strains. The Lactobacillus strains produced lactic acid at various concentrations. Compared with other strains, maximum level of lactic acid (3.1 g/L), hydrogen peroxide (4.31 mM) and bacteriocin (31 AU/mg) was detected in LB049. The inhibitory activity of culture supernatant against various bacterial pathogens was observed. The zone of inhibition ranged between 6 ± 2 mm and 23 ± 2 mm. The cell free extract showed activity against, Escherichia coli (ATCC 10536), Salmonella enteritidis (ATCC 13076), Shigella flexneri (ATCC 29903), and Enterococcus faecium (ATCC 8459). Consequently, L. plantarum LP049 may be considered as a potential candidate for the production of novel bioactive metabolites for therapeutic and bio-protective applications.     

Assessment of the probiotic potential of lactic acid bacteria isolated from kefir grains: evaluation of adhesion and antiproliferative properties in in vitro experimental systems

The main objective of this study was to isolate lactic acid bacteria from kefir grains and investigate their probiotic potential. In this study, 48 bacterial strains were isolated from kefir grains, whereas 39 strains were categorized to the genus Lactobacillus. Evaluation of the probiotic potential of the isolated stains was performed, including resistance to low pH, tolerance to pepsin, pancreatin and bile salts, and antibiotic resistance. In addition, evaluation of adhesion and antiproliferative properties in in vitro experimental systems was also conducted. Strains SP2 and SP5 that displayed the best performance in the conducted in vitro tests were selected for further studies. Firstly, genotypic identification of the two strains was performed by partial 16S rRNA gene sequencing, BLAST analysis, and species-specific multiplex PCR assay. The two strains were confirmed to be Pediococcus pentosaceus SP2 and Lactobacillus paracasei SP5. Then, the adhesion properties of the two strains were examined in vitro. Both strains displayed substantial adherence capacity to HT-29 human colon cancer cells. Moreover, a significant decrease of HT-29 cell growth after treatment with viable P. pentosaceus SP2 or L. paracasei SP5 was recorded. In addition, downregulation of anti-apoptotic genes and over-expression of cell cycle–related genes was recorded by real-time PCR analysis. Treatment with conditioned media of the two strains also caused significant reduction of cancer cell proliferation in a time- and concentration-dependent manner. P. pentosaceus SP2 and L. paracasei SP5 displayed the best probiotic properties that exerted substantial adherence on human colon cancer cells as well as significant anti-proliferative properties.